TIGIT

Ahmed Rishiq1, Reem Bsoul2, Ophir Pick1

  • 1The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada (IMRIC), Hebrew University-Hadassah Medical School, Jerusalem, Israel.

Oncoimmunology
|June 1, 2023
PubMed
概括

鼠标TIGIT是一种抑制受体,只与PVR相互作用. 消除TIGIT可以增强天然杀手细胞对瘤的活性,在体内减缓癌症的进展,并改善瘤细胞的杀死.